GILL SIMBA
Insider CIK 1180763 · EVLO President & CEO, Director · SER Director · FHTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 28,000 | $4.08 | $114.2K | 28,000 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award deriv | 2026-02-03 | 2026-02-17 | 92,000 | — | $0 | 92,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2025-06-17 | 2025-06-17 | 25,000 | $4.79 | $119.8K | 25,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 16,000 | $5.52 | $88.3K | 16,000 | SEC↗ |
| SER Serina Therapeutics, Inc. | A Award deriv | 2024-04-15 | 2024-04-17 | 295,300 | — | $0 | 295,300 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | S Sale | 2023-11-08 | 2023-11-08 | 172 | $0.33 | $57 | 17,758 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise deriv | 2023-11-07 | 2023-11-08 | 1,172 | — | $0 | 15,236 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise | 2023-11-07 | 2023-11-08 | 1,172 | — | $0 | 17,930 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | S Sale | 2023-09-28 | 2023-09-29 | 1,996 | $3.94 | $7.9K | 16,758 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2023-09-27 | 2023-09-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise deriv | 2023-09-27 | 2023-09-29 | 15,000 | — | $0 | 45,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise | 2023-09-27 | 2023-09-29 | 15,000 | — | $0 | 18,754 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | S Sale | 2023-08-08 | 2023-08-09 | 342 | $9.51 | $3.3K | 3,754 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise deriv | 2023-08-07 | 2023-08-09 | 1,171 | — | $0 | 16,408 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise | 2023-08-07 | 2023-08-09 | 1,171 | — | $0 | 4,096 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2023-06-21 | 2023-06-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | S Sale | 2023-05-08 | 2023-05-10 | 3,537 | $0.13 | $460 | 58,512 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise deriv | 2023-05-07 | 2023-05-09 | 23,437 | — | $0 | 351,563 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise deriv | 2023-05-07 | 2023-05-10 | 23,437 | — | $0 | 351,563 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise | 2023-05-07 | 2023-05-09 | 23,437 | — | $0 | 62,049 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2023-02-07 | 2023-02-09 | 375,000 | — | $0 | 375,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2023-02-07 | 2023-02-09 | 1,125,000 | — | $0 | 1,125,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | G Gift | 2022-09-13 | 2022-09-14 | 47,939 | — | $0 | 34,061 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | M Exercise deriv | 2022-09-12 | 2022-09-14 | 82,000 | — | $0 | 107,188 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | M Exercise | 2022-09-12 | 2022-09-14 | 82,000 | $0.73 | $59.9K | 82,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2022-06-21 | 2022-06-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2022-01-19 | 2022-01-21 | 300,000 | — | $0 | 300,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2021-07-13 | 2021-07-14 | 12,530 | — | $0 | 12,530 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2021-01-27 | 2021-01-29 | 275,000 | — | $0 | 275,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2020-01-28 | 2020-01-30 | 250,000 | — | $0 | 250,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2019-01-14 | 2019-01-16 | 220,000 | — | $0 | 220,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2018-05-08 | 2018-05-10 | 145,869 | — | $0 | 145,869 | SEC↗ |